[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Michal Nowicki\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":31},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":4,"targetDuration":4,"studyType":17,"phases":4,"briefSummary":18,"conditions":19,"keywords":21,"overallStatus":23,"whyStopped":4,"lastUpdateSubmitDate":24,"lastUpdatePostDateStruct":25,"startDateStruct":4,"completionDateStruct":4,"leadSponsor":28,"locationsCount":4},"100236426",false,"NCT02355782","OMS721 Compassionate Use in Patients With Thrombotic Microangiopathy","Provision of OMS721 to Patients With Thrombotic Microangiopathy Under Compassionate Use","Inclusion Criteria:\n\n* Have a diagnosis of thrombotic microangiopathy related to aHUS, TTP or stem cell transplant.\n* Have completed treatment in clinical trial OMS721-TMA-001.\n* Investigator determined that continued treatment with OMS721 could be beneficial.\n* Aged 18 years or older.\n\nExclusion Criteria:\n\n* Hypersensitivity to OMS721 or any excipients.\n* Have a serious medical condition that increases the risk of OMS721 treatment to the patient.","ALL","18 Years","EXPANDED_ACCESS","The purpose of this compassionate use study, for two patients with thrombotic microangiopathy, is to provide expanded access to patients who have participated in the clinical trial OMS721-TMA-001 and in whom improvement in their disease markers was observed while on treatment or to patients who could otherwise benefit from the treatment. This is a treatment protocol; not a research protocol.Therefore, only patients in study OMS721-TMA-001 deemed eligible by the investigator may participate.",[20],"Thrombotic Microangiopathy",[22],"TMA, aHUS, TTP, stem cell transplant-associated TMA","AVAILABLE","2015-04-14",{"date":26,"type":27},"2015-04-15","ESTIMATED",{"name":29,"class":30},"Michal Nowicki","OTHER",""]